Latest S-1 registration statements

Vivos Therapeutics has filed a registration statement for the resale of up to 1,737,259 shares of common stock by a selling stockholder, derived from warrants issued in private placements.

LENZ Therapeutics files an amendment to its S-1 registration statement, covering the resale of 1,297,411 shares of common stock issued in a PIPE financing following its recent merger with Graphite Bio.

Invech Holdings, Inc., a public company compliance firm, has filed an amendment to its S-1 registration statement, seeking to register 3.28 million shares of common stock for resale by existing shareholders.

NextTrip, Inc. plans a firm commitment public offering of common stock and warrants to advance its travel technology solutions.

HWH International Inc. has filed a registration statement for the resale of up to 149,443 shares of its common stock by selling stockholders, primarily related to a debt satisfaction agreement.

Calidi Biotherapeutics plans to offer common stock units and pre-funded warrant units, along with associated warrants, aiming to raise capital for working capital and general corporate purposes.

Centuri Holdings, a utility infrastructure services company, has filed an amendment to its Form S-1 registration statement, outlining details for a $299 million initial public offering and a concurrent private placement with Icahn Partners.

Odysight.ai has filed an amendment to its Form S-1 registration statement to register the resale of up to 11,046,927 shares of common stock by selling stockholders.

Ainos, Inc. has filed a registration statement for the resale of up to 4,430,732 shares of its common stock by selling stockholders.

BestGofer Inc., a development stage company with no active business operations, files an amendment to its registration statement for a secondary offering of 2,080,000 common shares by selling shareholders at $0.04 per share.

Star Alliance International Corp. has filed an amendment to its registration statement, potentially allowing a selling stockholder to offer up to 75 million shares of common stock.

Livento Group aims to register up to 83.3 million shares of common stock for potential sale by selling stockholders, including shares issuable under an Equity Line Purchase Agreement and upon exercise of warrants.

Ibotta, Inc., a leading digital marketing platform, has filed for an initial public offering, seeking to expand its innovative Ibotta Performance Network (IPN) that connects consumer packaged goods (CPG) brands with over 200 million consumers.

PACS Group, a leading post-acute healthcare company, has filed an amendment to its S-1 registration statement for an initial public offering of 19,050,000 shares of common stock, with plans to list on the NYSE under the symbol PACS.

Allarity Therapeutics aims to raise up to $8 million through a best efforts offering of common stock, warrants, and pre-funded warrants to advance its stenoparib clinical trial and potentially repurchase Series A Preferred Stock.

New Horizon Aircraft Ltd. files an amendment to its S-1 registration statement, outlining potential sales of Class A ordinary shares and warrants by existing security holders, as well as the issuance of shares upon warrant exercises.

Aethlon Medical launches a best-efforts offering of common stock and warrants, aiming to raise capital for research, clinical trials, and general corporate purposes.

Aspira Women's Health is registering for resale up to 1,571,000 shares of its common stock, issuable upon the exercise of warrants previously issued in a private placement.

Longeveron Inc. is offering up to 2,461,538 shares of Class A common stock along with warrants to fund clinical trials and general corporate purposes.

Envirotech Vehicles is seeking to raise capital through an offering of common stock and pre-funded warrants.

Shuttle Pharmaceuticals Holdings, Inc. is launching a rights offering to raise up to $4.5 million to support its Shuttle Diagnostics subsidiary and for general corporate purposes.

Correlate Energy Corp. has filed an amendment to its registration statement for a proposed public offering of units, pre-funded units, and underlying common stock and warrants, contingent upon NYSE listing.

Envoy Medical seeks to register the issuance and resale of Class A Common Stock and warrants, potentially raising $203.4 million for general corporate purposes.

Cardiff Lexington Corporation files an amendment to its Form S-1/A registration statement, aiming to offer 1,600,000 shares of common stock and uplist to NYSE American under the symbol CDIX.

Ascent Solar Technologies aims to raise $6 million through a public offering of common stock and pre-funded warrants, with Dawson James Securities acting as the exclusive placement agent.

Skye Bioscience files an amendment to its S-1 registration statement to correct a scrivener's error in the auditor's report regarding the date of the original report.

bioAffinity Technologies is registering for the resale of up to 1.63 million shares of its common stock by selling stockholders after a recent $2.5 million private placement.

Shorepower Technologies aims to register the resale of 25,817,272 shares of common stock, including shares held by selling stockholders and those underlying warrants.

BestGofer Inc. has filed an amendment to its S-1 registration statement to register 2,080,000 shares of common stock for offering by selling shareholders.

Fly-E Group, an electric vehicle company, has filed Amendment No. 1 to its Form S-1 registration statement with the SEC for its proposed initial public offering of 3,000,000 shares of common stock.